The authors of this report stress the importance of awareness of COVID-19–related complications in young patients who have Duchenne muscular dystrophy, paying particular attention to a potential higher risk of respiratory infections in these patients.
Spontaneous pneumothorax, or collapsed lung absent a trauma-related cause, necessitated the placement of chest tubes in a 25-year-old male patient who had Duchenne muscular dystrophy (DMD), with the authors of a new case report emphasizing treatment teams should be away of the signs of respiratory compromise in patients who have the inherited neuromuscular disorder. This is especially important in the context of recovery from COVID-19 in these patients, as their weakened respiratory muscles place them at a potentially higher risk of respiratory infection.
Publishing their report in Cureus, the authors wrote, “The annual incidence of spontaneous secondary pneumothorax is approximately 6.3 per 100,000 men and 2 per 100,000 women. On the contrary, the ratio is elevated up to 18% among DMD patients. Recognizing symptoms such as dyspnea, chest pain, and hypoxia is crucial for timely intervention.”1
The patient in this report presented to the hospital with an already complex medical history: mild restrictive lung disease, scoliosis with spinal fusion at multiple levels, hypothyroidism, COVID-19 infection 7 months prior, and pleurodesis 2 weeks prior. At presentation, he had right-sided chest pain and dyspnea, but stable vital signs. His chest x-ray revealed a pneumothorax that involved several sections of his right lung, and his chest CT, that this was large in scope.
A chest tube was placed and several additional procedures performed to aid in resolving the pneumothorax: a thoracoscopy, which looks at the chest area outside the lungs; a right-lobe wedge resection, in which small part of the damaged lung is removed; an apical blebectomy, in which damaged air sacs are removed; and mechanical pleurodesis, which is when pleural spaces are eliminated to prevent fluid buildup.
The chest tubes were left in for 6 days, and on day 9 following surgery, the patient was discharged.
When discussing this case, the report authors highlighted how the weakened respiratory muscles of patients who have DMD predispose this patient population to a host of complications that include chronic respiratory failure, ineffective cough, and nocturnal hypoventilation. However, the causes of spontaneous pneumothorax remain in question. What is known is that among patients who have comorbid COVID-19, 1 in 99 patients experiences a spontaneous pneumothorax, and that the mortality rate considering the presence of both conditions is higher compared with patients who have DMD but not COVID-19.2
Managing these patients can be challenging, they added, due to the lack of guidance and an array of treatments with such dependable variables as pneumothorax size, symptoms, and etiology. Further, treatment strategies need to minimize potential for additional deterioration and worsening of pneumothorax from use of noninvasive ventilation. They stress the significance of respiratory function monitoring in ambulatory and nonambulatory patients.
“These patients face an increased risk of mortality, emphasizing the need for careful evaluation and cautious measures, including the identification of pleural blebs or bullae and careful noninvasive positive pressure ventilation use,” they concluded. “Further research and investigation are necessary to enhance our understanding and refine treatment strategies for managing pneumothorax in this specific patient population.”
References
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More